Collegium Pharmaceutical, Inc
COLL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001267565
No open-market purchases or sales by Collegium Pharmaceutical, Inc insiders were filed in the last 90 days; 279 institutions reported holding it in 13F filings for Q2 2026, worth $1.42B in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Collegium Pharmaceutical, Inc changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Of which not filed for Q2 2021 | Q2 2021 | Change |
|---|---|---|---|---|
| Holders | 163 | 2 | 159 | −2 |
| Shares | 38.0M | 27.1K | 38.0M | +17.6K (0.0%) |
| Value | $900.7M | $643.0K | $898.3M | −$1.70M (−0.2%) |
2 institutions that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Collegium Pharmaceutical, Inc at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| South Dakota Investment Council | 106,182 | $2.51M | 0.04% |
| Pacer Advisors, Inc. | 90,402 | $2.14M | 0.03% |
| Maverick Capital LtdSuperinvestorMaverick Capital | 33,751 | $798.0K | 0.01% |
| Summit Global Investments | 28,700 | $678.0K | 0.04% |
| HRT Financial LP | 21,774 | $514.0K | 0.00% |
| Amalgamated Bank | 18,933 | $448.0K | 0.00% |
| Prairiewood Capital, LLC | 17,208 | $407.0K | 0.35% |
| Allianz Asset Management GmbH | 14,282 | $337.0K | 0.00% |
| Marshall Wace, LLP | 11,718 | $277.0K | 0.00% |
| Gotham Asset Management, LLC | 11,348 | $268.0K | 0.01% |
| Susquehanna International Group, LLP | 9,734 | $230.0K | 0.00% |
| Everence Capital Management Inc | 9,560 | $226.0K | 0.02% |
| Sutton Wealth Advisors Inc. | 371 | $8.77K | 0.00% |
| TCI Wealth Advisors, Inc. | 111 | $3.00K | 0.00% |
| Creative Financial Designs Inc | 100 | $2.00K | 0.00% |
| Parkside Financial Bank & Trust | 72 | $2.00K | 0.00% |
| US Bancorp | 31 | $1.00K | 0.00% |
Sold out (19)
Institutions that held Collegium Pharmaceutical, Inc at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Avidity Partners Management LP | 740,000 | $17.5M |
| Silvercrest Asset Management Group LLC | 223,840 | $5.30M |
| Point72 Asset Management, L.P. | 133,522 | $3.16M |
| California Public Employees Retirement System | 70,200 | $1.66M |
| Jackson Creek Investment Advisors LLC | 46,575 | $1.10M |
| Oberweis Asset Management Inc | 41,200 | $976.0K |
| Skandinaviska Enskilda Banken AB (publ) | 33,300 | $789.0K |
| Hancock Whitney Corp | 21,764 | $516.0K |
| Trexquant Investment LP | 20,174 | $478.0K |
| Jump Financial, LLC | 14,852 | $352.0K |
| Diametric Capital, LP | 13,519 | $320.0K |
| SG Americas Securities, LLC | 9,918 | $235.0K |
| Eqis Capital Management, Inc. | 8,942 | $212.0K |
| Prelude Capital Management, LLC | 8,871 | $210.0K |
| Jefferies Group LLC | 6,500 | $154.1K |
| FORA Capital, LLC | 1,336 | $32.0K |
| Acadian Asset Management LLC | 1,067 | $25.0K |
| International Assets Investment Management, LLC | 800 | $16.0K |
| Harbour Investments, Inc. | 429 | $10.0K |
Not filed for Q2 2021 yet (2)
Institutions that held Collegium Pharmaceutical, Inc at the end of Q1 2021 and haven't filed a 13F for Q2 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| OneAscent Wealth Management LLC | 18,662 | $442.0K |
| OneAscent Financial Services LLC | 8,477 | $201.0K |